XML 31 R4.htm IDEA: XBRL DOCUMENT v3.24.0.1
Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Operating expenses:    
Research and development $ 27,670 $ 24,250
General and administrative 14,088 12,276
Total operating expenses 41,758 36,526
Loss from operations (41,758) (36,526)
Other income (expense), net 4,809 1,171
Net loss $ (36,949) $ (35,355)
Net loss per share, basic $ (0.84) $ (1.37)
Net loss per share, diluted $ (0.84) $ (1.37)
Weighted average common shares outstanding, basic 43,901,241 25,761,394
Weighted average common shares outstanding, diluted 43,901,241 25,761,394
Comprehensive loss:    
Net Income (Loss) $ (36,949) $ (35,355)
Other comprehensive loss:    
Unrealized gain (loss) on marketable securities 112 (31)
Total other comprehensive gain (loss) 112 (31)
Total comprehensive loss $ (36,837) $ (35,386)